(Q61981289)

English

Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase 1, Randomized, Double-Blind, Pharmacokinetic and Glucodynamic 6-Way Crossover Study of SC Administered Insulin Lispro With Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin With Recombinant Human Hyaluronidase (rHuPH20) Compared to Insulin Lispro Alone in Healthy Volunteers (English)

0 references

medical condition

diabetes

0 references

sponsor

Halozyme Therapeutics

0 references

country

United States of America

0 references

main subject

hyaluronidase (human recombinant)